EV/EBITDA
-1.97
+0.03+1.50%
Fri, 21 Feb 2025 21:05:03 GMT
Summary
- As of February 24, 2025, GRCE EV/EBITDA is -1.97, with a rise of +0.03 (+1.50%) during the most recent trading day.
- Over the past year, GRCE EV/EBITDA has dropped by -0.92 (-87.62%).
- GRCE EV/EBITDA is now -109.77% below its all-time high of 20.17.
Performance
GRCE EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
GRCE EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +1.5% | -1.2% | -0.9% |
| 1 m1 month | -22.4% | +22.4% | -12.3% |
| 3 m3 months | -79.1% | +87.6% | +1.9% |
| 6 m6 months | -369.1% | +494.7% | +33.7% |
| ytdytd | -22.4% | +22.8% | -12.0% |
| 1 y1 year | -87.6% | +156.4% | -1.5% |
| 5 y5 years | -222.9% | +2.0% | -87.8% |
GRCE EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -62.8% | -2.13 | +7.5% | |
| 3 m | 3-month | -1.10 | -79.1% | -2.13 | +7.5% |
| 6 m | 6-month | -0.35 | -462.9% | -2.13 | +7.5% |
| 1 y | 1-year | -0.14 | -1307.1% | -2.13 | +7.5% |
| 3 y | 3-year | 1.02 | -293.1% | -2.13 | +7.5% |
| 5 y | 5-year | 20.17 | -109.8% | -116.54 | +98.3% |
| alltime | all time | 20.17 | -109.8% | -1564 | +99.9% |
Grace Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.97(+22.4%) |
| 2024 | -1.61(+126.8%) |
| 2023 | -0.71(-473.7%) |
| 2022 | 0.19(-110.7%) |
| 2021 | -1.78(-166.4%) |
| 2020 | 2.68(-172.2%) |
| 2019 | -3.71(+150.7%) |
| Date | Value |
|---|---|
| 2018 | -1.48(-10.8%) |
| 2017 | -1.66(-25.9%) |
| 2016 | -2.24(+14.9%) |
| 2015 | -1.95(-99.9%) |
| 2014 | -1367.08(>+9900.0%) |
| 2013 | -12.37(-92.1%) |
| 2012 | -157.17 |
FAQ
- What is Grace Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Grace Therapeutics?
- What is GRCE EV/EBITDA year-to-date change?
- What is Grace Therapeutics EV/EBITDA year-on-year change?
What is Grace Therapeutics EV/EBITDA?
The current EV/EBITDA of GRCE is -1.97
What is the all time high EV/EBITDA for Grace Therapeutics?
Grace Therapeutics all-time high EV/EBITDA is 20.17
What is GRCE EV/EBITDA year-to-date change?
Grace Therapeutics EV/EBITDA has changed by -0.36 (-22.36%) since the beginning of the year
What is Grace Therapeutics EV/EBITDA year-on-year change?
Over the past year, GRCE EV/EBITDA has changed by -0.92 (-87.62%)